Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceutical ingredients REACH PRE-REGISTRATION ENDS TODAY: ECHA Opens Back-up System as Applications Top 2 MillionDow, PIC Renegotiate Terms of K-Dow; Sign Binding AgreementReach Pre-registrations Top 1.6 Million with 3 Days to GoR Mukundan to Take Over as Managing Director of Tata ChemicalsEvonik Sells U.K. Site to Management Related Stories Phenol Fire Closes Channel TunnelAkzoNobel Unveils $100-Million Cost Reduction Program, to Cut 3,500 JobsCPhI: Dow Brings Synthetic Glycerine Business Back Under its DomainJohnson Matthey Completes Sale of Ceramic Insulator and Alumina BusinessesChemspec Europe: EU Industry Carves Out Supply Chain Quality Assurance Program

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

June 30, 2008

AllessaChemie Enjoys Rapid Growth Trajectory, Develops Novel R&D Model

Alex Scott in Münich

AllessaChemie (Frankfurt), Europe’s largest privately owned toll manufacturer of non-GMP specialty chemicals, told CW at the recently held Chemspec Europe expo in Münich that its sales of its project-based business have grown...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers